As the primary pediatric cancer provider and the only National Cancer Institute (NCI) Children’s Oncology Group institution in the Midwest Cancer Alliance, Children’s Mercy is the pediatric consortium partner for the National Cancer Institute-designated The University of Kansas Cancer Center and the Stowers Institute for Medical Research. This partnership offers progress in cutting-edge cancer research focused on unique tumors arising in children.
The University of Kansas Cancer Center remains one of only 69 nationally designated centers by the National Cancer Institute, a part of the National Institutes of Health. The Stowers Institute for Medical Research remains a significant part of the community-wide effort to transform cancer research and clinical care.
The strength in pharmacogenomics and genomics at Children’s Mercy, opens up new avenues for diagnosis and treatment of various forms of childhood cancer. Combining these strengths with the full range of expertise at The University of Kansas Cancer Center offers hope for current and future patients fighting cancer.
Learn more about the Division of Hematology, Oncology and Bone Marrow Transplantation.
Pictured above (left to right):
Roy Jenson, MD, Director of The University of Kansas Cancer Center
Randall L. O’Donnell, PhD, President and Chief Executive Officer of Children’s Mercy
David Chao, PhD, President and Chief Executive Officer of the Stowers Institute for Medical Research
Tom Curran, PhD, Executive Director of the Children’s Mercy Children’s Research Institute